title: The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
authors.affiliation: Humanitas Cancer Center, Istituto Clinico Humanitas, Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Rimondo
authors.affiliation: Humanitas Cancer Center, Istituto Clinico Humanitas, Milan, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Crocchiolo
authors.affiliation: Oncology-hematology, Bone Marrow Transplantation Program, American University of Beirut, Beirut, Lebanon.
authors.forename: J
authors.initials: J
authors.lastname: El-Cheikh
authors.affiliation: Humanitas Cancer Center, Istituto Clinico Humanitas, Milan, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Bramanti
authors.affiliation: Department of Hematology, Transplantation Program, Institut Paoli Calmettes, Marseille, France.
authors.forename: A
authors.initials: A
authors.lastname: Granata
authors.affiliation: Department of Hematology, Transplantation Program, Institut Paoli Calmettes, Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Furst
authors.affiliation: Humanitas Cancer Center, Istituto Clinico Humanitas, Milan, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Sarina
authors.affiliation: Humanitas Cancer Center, Istituto Clinico Humanitas, Milan, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Morabito
authors.affiliation: Department of Hematology, Transplantation Program, Institut Paoli Calmettes, Marseille, France.
authors.forename: R
authors.initials: R
authors.lastname: Devillier
authors.affiliation: Department of Hematology, Transplantation Program, Institut Paoli Calmettes, Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Harbi
authors.affiliation: Department of Hematology, Transplantation Program, Institut Paoli Calmettes, Marseille, France.
authors.forename: B
authors.initials: B
authors.lastname: Mohty
authors.affiliation: Molecular Biology Section, Clinical Investigation Laboratory, Istituto Clinico Humanitas, Milan, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Mineri
authors.affiliation: Department of Hematology, Transplantation Program, Institut Paoli Calmettes, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Faucher
authors.affiliation: Cell Therapy Unit, Institut Paoli Calmettes, Marseille, France.|Aix-Marseille Université, Marseille, France.|Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Chabannon
authors.affiliation: Humanitas Cancer Center, Istituto Clinico Humanitas, Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Santoro
authors.affiliation: Department of Hematology, Transplantation Program, Institut Paoli Calmettes, Marseille, France.|Aix-Marseille Université, Marseille, France.|Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.
authors.forename: D
authors.initials: D
authors.lastname: Blaise
authors.affiliation: Humanitas Cancer Center, Istituto Clinico Humanitas, Milan, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Castagna
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology / Q000627:therapeutic use*; D065095:Calcineurin Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use*; D003556:Cystitis / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D008297:Male; D011120:Polyomavirus / Q000472:pathogenicity*; D012189:Retrospective Studies; D019172:Transplantation Conditioning / Q000009:adverse effects* / Q000379:methods
chemical_list: D018906:Antineoplastic Agents, Alkylating; D065095:Calcineurin Inhibitors; D003520:Cyclophosphamide